Ad Header



The Pulse of the Pharmaceutical Industry

Updated Direct-to-Consumer Awareness Campaign Available for LINZESS

Written by: | | Dated: Wednesday, April 15th, 2015

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. announced today the launch of an updated direct-to-consumer (DTC) awareness campaign for LINZESS® (linaclotide).

Please see full Prescribing Information including Boxed Warning at company has made the television advertisement available on Business Wire’s website and YouTube channel. More information about LINZESS is available at

LINZESS® is a trademark owned by Ironwood Pharmaceuticals, Inc. Any other trademarks referred to in this alert are the property of their respective owners. All rights reserved.


Ironwood Pharmaceuticals, Inc.
Media Relations:
Trista Morrison, 617374-5095
Investor Relations:
Meredith Kaya, 617-374-5082

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom